While our expertise is broad, we currently focus on the pharmaceutical and energy industries – two areas in which we have a deep understanding and experience:
Pharmaceutical and medical devices – We help raise capital and/or product sales, along with consulting and advisory services for companies with post–FDA/CE/CFDA products. Our team assists these companies in commercializing their products in the China market via mergers & acquisitions (M&A), direct product sales, and licensing agreements.
Energy – We assist our clients with cross border energy deals, the structure of deals, and project finance services, in addition to interim CXO services, consulting and advisory services. The average size of the deals and projects range from $50 million to $2 billion in the US, Canada, Latin America, Southeast Asia, and Europe. Transaction types include debt/bond, M&A, business development and technology licensing.